recombinant adenovirus-interferon/Syn3
Term · Oncology and biomedicine · MLC-T-ONC-016385
A non-replicating recombinant adenovirus type 5 (Ad5)-vector encoding the gene for interferon alpha-2b (IFNα2b) and the gene transfer enhancement agent Syn 3, with potential antineoplastic activity. Upon intravesical administration, recombinant adenovirus-interferon with Syn3 transfects both cancerous and normal bladder cells, and the adenovirus secretes interferon (IFNα2b) into the bladder. IFN exerts a direct antitumor killing effect and a bystander effect, thereby killing adjacent, non-transfected cancerous bladder cells. Syn 3 enhances the ability of the adenoviral vector to transfect cells.
| Identifier | MLC-T-ONC-016385 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | rAd-IFN/Syn3; recombinant adenovirus-interferon with Syn3 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-016385",
"term": "recombinant adenovirus-interferon/Syn3",
"field": "Oncology and biomedicine",
"definition": "A non-replicating recombinant adenovirus type 5 (Ad5)-vector encoding the gene for interferon alpha-2b (IFNα2b) and the gene transfer enhancement agent Syn 3, with potential antineoplastic activity. Upon intravesical administration, recombinant adenovirus-interferon with Syn3 transfects both cancerous and normal bladder cells, and the adenovirus secretes interferon (IFNα2b) into the bladder. IFN exerts a direct antitumor killing effect and a bystander effect, thereby killing adjacent, non-transfected cancerous bladder cells. Syn 3 enhances the ability of the adenoviral vector to transfect cells.",
"synonyms": [
"rAd-IFN/Syn3",
"recombinant adenovirus-interferon with Syn3"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/recombinant-adenovirus-interferon-syn3/"
}
Record 14,125 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.